Top 50 Medical Device VC Funds & Investors in Switzerland (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Zürcher Kantonal Bank
VC Fund
|
28 | Switzerland, Germany, Japan | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $1M–$20M |
|
Foundation for Innovation and Technology (FIT)
VC Fund
|
28 | Switzerland, France, United States | Debt Financing, Grant, Seed | Health Care, Information Technology, Artificial Intelligence | $20k–$2.5M |
|
Verve Ventures
VC Fund
|
18 | Switzerland, Germany, France | Series A, Seed, Series B | Software, Health Care, Biotechnology | $1.3M–$45M |
|
VI Partners
VC Fund
|
9 | Switzerland, Germany, United States | Series A, Series B, Series C | Health Care, Biotechnology, Software | $3.2M–$100M |
|
4FOX Ventures
VC Fund
|
9 | Switzerland, United States | Series A, Seed, Series B | Medical Device, Medical, Health Care | $1.8M–$69M |
|
StartAngels Network
VC Fund
|
7 | Switzerland, Brazil | Seed, Series A, Series B | Health Care, Medical, Medical Device | $933k–$5.7M |
|
Zühlke Ventures AG
VC Fund
|
6 | Switzerland, Sweden, United States | Series A, Seed, Series B | Health Care, Medical Device, Medical | $1.1M–$11M |
|
OCCIDENT
VC Fund
|
6 | Switzerland, Germany, Finland | Series A, Seed, Series C | Health Care, Biotechnology, Medical Device | $758k–$401M |
|
BioMedPartners
VC Fund
|
5 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5.3M–$75M |
|
BlueOcean Ventures
VC Fund
|
5 | Switzerland, India, France | Seed, Series A, Series B | Health Care, Medical, Personal Health | $1M–$20M |
|
redalpine
VC Fund
|
5 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Health Care, Biotechnology | $1.6M–$125M |
|
Translink Capital
VC Fund
|
5 | United States, China, South Korea | Series A, Series B, Series C | Software, Artificial Intelligence, Information Technology | $4.1M–$58M |
|
SICTIC
VC Fund
|
5 | Switzerland, Germany, Tanzania | Seed, Venture - Series Unknown, Pre-Seed | Software, Artificial Intelligence, Information Technology | $264k–$11M |
|
Kickfund
VC Fund
|
5 | Switzerland, France, Germany | Seed, Pre-Seed, Convertible Note | Health Care, Biotechnology, Manufacturing | $110k–$5.7M |
|
M Ventures
VC Fund
|
4 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Alpana Ventures
VC Fund
|
4 | United States, Switzerland, Germany | Seed, Series A, Series B | Software, FinTech, Health Care | $729k–$45M |
|
EIT Health
VC Fund
|
4 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $27k–$1.7M |
|
Innosuisse
VC Fund
|
4 | Switzerland, United States, United Kingdom | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Medical | $16k–$16M |
|
Kinled Holding
VC Fund
|
3 | United Kingdom, United States, Switzerland | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Software | $594k–$40M |
|
415 Capital
VC Fund
|
3 | United States, Switzerland, France | Series A, Series B, Series C | Medical Device, Medical, Health Care | $5.2M–$87M |
|
VitaTech S.A
VC Fund
|
3 | Switzerland, United States | Series A, Seed | Biotechnology, Medical Device, Therapeutics | |
|
3wVentures
VC Fund
|
3 | Switzerland, Spain, Austria | Seed, Angel, Series A | Software, Health Care, Search Engine | $50k–$8M |
|
Neomed Management
VC Fund
|
3 | Switzerland, United States, Sweden | Series B, Series C, Series A | Health Care, Biotechnology, Medical | $8.3M–$42M |
|
S2S Ventures
VC Fund
|
3 | Switzerland, Germany | Pre-Seed, Seed | Health Care, Artificial Intelligence, Manufacturing | $28k–$3.4M |
|
EVA Basel
VC Fund
|
3 | Switzerland | Seed, Series A | Biotechnology, Medical Device, Pharmaceutical | $1.9M–$3.7M |
|
Simple Data
VC Fund
|
3 | Switzerland | Pre-Seed, Convertible Note | Medical, Privacy, Software | $87k–$322k |
|
Fongit Seed Invest
VC Fund
|
3 | Switzerland | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $1M–$3.3M |
|
Foundation for technological innovation
VC Fund
|
2 | Switzerland | Pre-Seed, Debt Financing | Medical, Health Care, Medical Device | $124k–$560k |
|
Serpentine Ventures
VC Fund
|
2 | Switzerland, Germany, United States | Seed, Pre-Seed | Software, Information Technology, Automotive | $110k–$6.3M |
|
Evercurious VC
VC Fund
|
2 | Switzerland, Belgium, Germany | Seed, Pre-Seed, Series A | Health Care, Manufacturing, Medical | $111k–$7.7M |
|
Sparks Street Capital
VC Fund
|
2 | Switzerland | Seed | Wearables, Health Care, Medical Device | $4.1M–$6.1M |
|
Höhle der Löwen Schweiz
VC Fund
|
2 | Switzerland | Seed, Angel | E-Commerce, Retail, Farming | $100k–$1.3M |
|
Privilège Ventures
VC Fund
|
2 | Switzerland, Italy, France | Seed, Pre-Seed, Series A | Health Care, Software, Wearables | $667k–$7M |
|
EuroUS Ventures
VC Fund
|
2 | Switzerland, Israel, Austria | Series A, Venture - Series Unknown, Seed | Software, Health Care, Medical Device | $500k–$14M |
|
Schroder Adveq
VC Fund
|
2 | Switzerland, United States, India | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $5M–$100M |
|
Wyss Center
VC Fund
|
2 | Switzerland | Seed, Grant, Series A | Medical, Manufacturing, Medical Device | $109k–$109k |
|
Lichtsteiner Foundation
VC Fund
|
2 | Switzerland | Seed, Series A | Biotechnology, Health Care, Medical | $1.6M–$6.8M |
|
Astanor Ventures
VC Fund
|
2 | United States, France, United Kingdom | Series A, Seed, Series B | Agriculture, Biotechnology, AgTech | $442k–$61M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
2 | Germany, Switzerland, United States | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Health Care | $680k–$31M |
|
Inkef
VC Fund
|
2 | The Netherlands, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $3.1M–$86M |
|
TiVentures
VC Fund
|
2 | Switzerland, Italy, United States | Seed, Series A, Pre-Seed | Software, SaaS, Energy | $497k–$3.3M |
|
Molten Ventures
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $3.2M–$200M |
|
Ecosystem Ventures
VC Fund
|
2 | United States, India, Switzerland | Seed, Series A, Angel | Mobile Apps, Mobile, Finance | $203k–$15M |
|
Swisscom Ventures
VC Fund
|
2 | Switzerland, United States, United Kingdom | Series B, Series A, Series C | Software, SaaS, Information Technology | $2M–$80M |
|
BB Biotech Ventures
VC Fund
|
2 | United States, Switzerland, Italy | Series C, Series A, Series B | Biotechnology, Health Care, Medical | $1.4M–$132M |
|
Polytech Ventures
VC Fund
|
2 | Switzerland, United States, Spain | Seed, Series A, Venture - Series Unknown | Software, Financial Services, FinTech | $500k–$10M |
|
Boltendahl International Partners
VC Fund
|
2 | United States, Israel, Switzerland | Series A, Angel, Series B | Mobile, Sensor, Medical | $9.7M–$18M |
|
Initiative Capital Romandie
VC Fund
|
2 | Switzerland | Series A, Series C, Series B | Health Care, Biotechnology, Medical Device | $6.8M–$41M |
|
New Enterprise Associates
VC Fund
|
2 | United States, China, India | Series A, Series B, Series C | Software, Health Care, Biotechnology | $5.7M–$100M |
| Access all 394 VC funds in Switzerland Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Germany, Japan
Investor stats
- Total investments: 208
- Round size: Seed $1M–$6M; Series A $2.1M–$13M; Series B $1.7M–$20M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $150M in 2024
Portfolio highlights
- Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
- QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
- Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more...Investment focus
- Industry: Health Care, Information Technology, Artificial Intelligence
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, France, United States
Investor stats
- Total investments: 292
- Round size: Seed $100k–$2.5M; Grant $20k–$125k; Debt Financing $100k–$532k
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- PolaSight — PolaSight delivers a direct, label free visualization of fresh tissue through its automated PolaOne benchtop polarimetric imaging platform. The technology utilizes multi spectral polarimetry to reveal quantitative physical contrast and microstructure details beyond what conventional stained slides show. This non destructive, AI ready optical mapping process provides standardized tissue data right at the bench without requiring freezing or chemical reagents.
- Swiss Soil — Live biological sensing, adaptive decision-making, and precision inputs that cut waste, respond to real conditions, and build healthier soil.
- Biodelphis Therapeutics — Swiss biotech developing next-generation protease inhibitors using Antibody-Peptide Inhibitor Conjugates (APIC).
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 308
- Round size: Seed $1.3M–$12M; Series A $2.1M–$18M; Series B $3.9M–$45M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $61M in 2022
Portfolio highlights
- Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
- Turn2x — TURN2X decarbonizes the industry by producing Renewable Natural Gas with a unique methanation process.
- Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 114
- Round size: Series A $3.2M–$23M; Series B $3.3M–$41M; Series C $7M–$100M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $110M in 2020
Portfolio highlights
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
- Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
4FO Ventures
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: Switzerland, United States
Investor stats
- Total investments: 23
- Round size: Seed $1.8M–$3.3M; Series A $1.8M–$11M; Series B $5.5M–$69M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Ecorobotix — Discover how Ecorobotix is revolutionizing precision agriculture with AI-driven field sprayers. Cut costs, boost yields, and farm smarter with precision ag technology.
- Neo Medical — Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Brazil
Investor stats
- Total investments: 31
- Round size: Seed $933k–$3.4M; Series A $2M–$3.3M; Series B $1.7M–$5.7M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Rflect — Rflect helps universities protect their business model in the age of AI by training the human skills machines cannot replace—reflection, resilience, collaboration—directly inside the curriculum for credit. As AI commoditizes knowledge and devalues degrees, Rflect secures degree value through measurable human development and audit-ready data foraccreditation, employability, and retention. Embedded as credit-bearing infrastructure, Rflect achieves 100% student usage, zero institutional churn, and long-term lock-in cycles.
- Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
- Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Sweden, United States
Investor stats
- Total investments: 15
- Round size: Seed $1.1M–$3M; Series A $7M–$11M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Bottneuro — Bottneuro strives to set new standards in personalized neuromodulation - achieving better results and improving quality of life. Find out more!
- Indivi — Healios CTMS provides the Digital Biomarker based technology and digital validation scales to improve and streamline research and clinical practice.
- PeriVision — At Perivision, we combine artificial intelligence (AI), virtual reality (VR) and the cloud to build the next generation systems to understand visual function. Our systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
OCCIDENT invests in deep tech start-ups with a focus on spin-offs originating from scientific research, thus having a real impact and enabling concrete solutions for different challenges facing society today. As an owner-managed venture capital investor with offices in Munich and Zug, OCCIDENT supports start-ups in the life sciences and industrial tech sectors from the seed stage onwards, accompanies their portolio companies over the long term both financially as well as with their extensive experience, and thus enables founding teams to achieve outstanding results. With a strong entrepreneurial mindset, OCCIDENT invests its own money and makes decisions based on sustainable potential for success. Co-operation with the founding teams of their portfolio companies motivates the OCCIDEN team and inspires them every day. They are energized by their passion and drive, and the often very intense exchange spurs them on to tackle challenges together. OCCIDENT’s aim with each and every one of their investments is to make a positve contribution to society in a sustainable way.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series C
- Geography: Switzerland, Germany, Finland
Investor stats
- Total investments: 41
- Round size: Seed $758k–$4.6M; Series A $2.2M–$12M; Series C $8.3M–$401M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 88
- Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $106M in 2018
Portfolio highlights
- T-CURX — T-CURX is a biotechnology company focused on the development of personalized cancer immunotherapies. Utilizing a proprietary platform, T-CURX aims to advance the field of T cell therapies to address the challenges faced in treating various cancers. The company's innovative approach involves the creation of a new generation of T cells designedto improve patient outcomes. As a spin-out from the University Clinics Würzburg, Germany, T-CURX leverages the expertise of its co-founders, including Prof. Michael Hudecek, to pioneer in the area of CAR-T cell-based medicines. With a commitment to transforming cancer treatment, T-CURX is at the forefront of developing targeted therapies that offer hope for a more effective and personalized approach to cancer care.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.
Show more...Investment focus
- Industry: Health Care, Medical, Personal Health
- Stage:Seed, Series A, Series B
- Geography: Switzerland, India, France
Investor stats
- Total investments: 18
- Round size: Seed $1M–$3.1M; Series A $2.3M–$20M; Series B $4M–$16M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- UGX.ai — Connect, process, and optimise industrial operations across manufacturing, OEM, and clean energy with UGX.AI.
- RockFlow — RockFlow is an investment wonderland for the young. Born to be brave, invest in the moment.
- official.fm — Officials.fm has done an incredible job at creating a community that brings together different artists and listeners in a very creative and dynamic way.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 207
- Round size: Seed $1.6M–$13M; Series A $2.8M–$33M; Series B $16M–$125M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $200M in 2024
Portfolio highlights
- calliora — Calliora develops an artificial intelligence platform designed to integrate hospital clinical documentation and coding systems to identify billing errors before invoices are sent to health insurers
- Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.
- Enact Intelligence — Enact Intelligence builds underlying technology for general-purpose robots, reimagining the entire robotic stack from the ground up to solve the ultimate bottleneck in robotics: dexterity. Rather than relying primarily on vision models, Enact builds proprietary actuators that measure force directly inside the joints. This creates a human-like "nervous system" and muscle feedback loop, allowing robots to efficiently learn and robustly execute highly precise, contact-rich physical tasks across industrial, retail, and manufacturing environments.
Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Series B, Series C
- Geography: United States, China, South Korea
Investor stats
- Total investments: 235
- Round size: Series A $4.1M–$24M; Series B $5M–$42M; Series C $8M–$58M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Musicshake — Founded in March 2005, Musicshake is the world's most fun and sophisticated online music community, allowing people to CREATE, LISTEN, DISCOVER and SHARE originally-created music. Musicshake provides a platform for non-artists to select from 1.3 million original music samples to create their original music, share and connect across the globeand also provide a way to monetize.Based in Los Angeles, the Musicshake team includes veterans and experts from the music, technology and entertainment industry. They continue to innovate with the promise to deliver the best user experience to both Musicshake application and the website.
- Footprintku — Footprintku AI transforms unstructured component datasheets into structured digital assets, delivering DFM-compliant ECAD Libraries that accelerate design workflows, reduce errors, and drive manufacturing efficiency.
- UBIAI Technology — UBIAI Technology is a car network big data application service company, dedicated to the mining and application of big data in the car network, in order to accelerate the transformation of car companies to service-oriented enterprises, and drive innovation in the industries of auto insurance, used cars and auto finance. .
SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Switzerland, Germany, Tanzania
Investor stats
- Total investments: 301
- Round size: Seed $504k–$3.7M; Pre-Seed $264k–$2.7M; Venture - Series Unknown $1.2M–$11M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
- Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
- Prevision Medicine — Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and deliver clinical insights.
Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Switzerland, France, Germany
Investor stats
- Total investments: 51
- Round size: Seed $1.1M–$5.7M; Pre-Seed $335k–$4M; Convertible Note $110k–$118k
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $80M in 2023
Portfolio highlights
- Bewelab SA — Bewe is a mobile game designed to reduce cravings, using neuroscience to automatically retrain your brain and effortlessly reclaim your health.
- Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
- Helix Robotics — We are building the first commercial soft manipulator
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 190
- Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Mueon — semiconductor-based systems for AI and hyperscale computing
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, Germany
Investor stats
- Total investments: 103
- Round size: Seed $729k–$4M; Series A $2.1M–$14M; Series B $3M–$45M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Sinay — Sinay provides numerous solutions for maritime sector stakeholders, such as collecting and analysing maritime data.
- Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
- Tinamu — Trusted inventory intelligence delivered in real-time
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 106
- Round size: Seed $220k–$1.4M; Grant $27k–$1.6M; Pre-Seed $45k–$1.7M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: Switzerland, United States, United Kingdom
Investor stats
- Total investments: 238
- Round size: Seed $500k–$16M; Grant $41k–$2.5M; Pre-Seed $16k–$4.3M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- Actival — Actival is driven by innovation and the integration of AI tools in dentistry. It is committed to precision and oral health.
- Precise Health — Why replace antibiotics when we can make them work better? AI reads the bacterial genome, matches the adjunct. Phages first.
- Release Therapeutics — A best in class, patented, platform technology for the local and targeted delivery of highly potent therapeutic proteins to the CNS and beyond. Release Therapeutics - Treating genetic disorders without gene therapies.
Kinled was founded in 1980 to retain the investment assets of the Aisher family. In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists. Since then, Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 144
- Round size: Seed $594k–$14M; Series A $1.7M–$40M; Venture - Series Unknown $1.6M–$13M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical device technologies. The firm invest in large unmet patient needs in chronic diseases, with an emphasis on cardio & neurovascular disorders, the worldwide leading causes of death and the largest cost driver in the global healthcare systems.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, France
Investor stats
- Total investments: 17
- Round size: Series A $5.2M–$37M; Series B $35M–$87M; Series C $30M–$80M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- ReEmerge — ReEmerge is a medical technology company that develops Cognitive Network Restoration Therapy, a neurostimulation approach designed to address chronic cognitive impairment following brain injury. Its technology uses targeted electrical stimulation of neural networks to activate underperforming but viable brain circuits, with the goal of improving cognitive function and supporting recovery in patients with persistent impairments.
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VitaTech S.A
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Therapeutics
- Stage:Series A, Seed
- Geography: Switzerland, United States
Investor stats
- Total investments: 4
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Aesyra — Aesyra makes innovative medical devices to help manage bruxism and improve your sleep.
- Gain Therapeutics — Discover Gain Therapeutics' next-gen allosteric small molecule therapies, combining physics-based methods and AI to address critical patient needs.
- Industrie Biomediche Insubri — IBI is an innovative hi-tech Swiss biomedical company focused on research, development and production of medical devices for tissue engineering and regenerative medicine: substitutes, grafts, 3D matrixes and 2D scaffolds.
3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
Show more...Investment focus
- Industry: Software, Health Care, Search Engine
- Stage:Seed, Angel, Series A
- Geography: Switzerland, Spain, Austria
Investor stats
- Total investments: 43
- Round size: Seed $50k–$3.5M; Angel $583k–$2.1M; Series A $1.1M–$8M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — raised $100M in 1999
Portfolio highlights
- Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
- GUURU Solutions — Discover how community-powered advice can turn your PDPs into trusted, high-converting content and get cited in AI search.
- Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date. NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that address substantial market opportunities in the pharmaceutical, medical device and diagnostics industries. NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America. From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies. NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C, Series A
- Geography: Switzerland, United States, Sweden
Investor stats
- Total investments: 46
- Round size: Series A $8.3M–$37M; Series B $21M–$42M; Series C $9.2M–$41M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $51M in 2015
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Oxular — Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
S2S Ventures is a fully student-led VC fund from Switzerland, backed by some of the country's most successful entrepreneurs.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Manufacturing
- Stage:Pre-Seed, Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 28
- Round size: Seed $954k–$3.4M; Pre-Seed $28k–$2.7M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $11M in 2021
Portfolio highlights
- Haicker — Continuous, automated vulnerability scanning for your web codebases. Cheaper, faster, and more efficient than traditional pentesters.
- Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
- Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western SwitzerlandThey support start-ups by helping to bridge the gap between their business idea and the successful commercialization of their life sciences projects, innovations and technologies.They provide thorough coaching and activelyencourage contact with their wide-ranging network of experts and investors as well as providing seed-phase investments.In science and technology transfer, they act as the link between researchers, universities’ scientific liaison offices, potential investors and the market.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Pharmaceutical
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 5
- Round size: Seed $1.9M–$3.7M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- POLYNEURON — Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patientswith immune disorders in a safe and effective manner.
- Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
- Inthera Bioscience — Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
Simple Data Sarl is an IT engineering company that specializes is custom solutions for businesses and individuals.
Show more...Investment focus
- Industry: Medical, Privacy, Software
- Stage:Pre-Seed, Convertible Note
- Geography: Switzerland
Investor stats
- Total investments: 3
- Round size: Pre-Seed $87k–$322k
- Lead/follow: 0% lead, 100% follow
Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Switzerland
Investor stats
- Total investments: 9
- Round size: Seed $1M–$1.4M; Series A $2.3M–$3.3M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- EBAMed — EBAMed builds CardioKit: live ultrasound that follows the heart during radiotherapy and gates the beam, whether the heart is the target or the organ to protect.
- Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
- Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Foundation for technological innovation provides support for start-up founders with projects based in the business and residential area.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Pre-Seed, Debt Financing
- Geography: Switzerland
Investor stats
- Total investments: 4
- Round size: Pre-Seed $284k–$560k; Debt Financing $124k–$124k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Gaia Tech — Gaia Technologies turns agricultural sidestreams into high-value ingredients for cosmetics, food, and feed manufacturers.
- Precisia Care — Precisia Care is a company that uses real-time clinical data obtained directly from hospital operations to make actionable AI-driven forecasts and recommendations.
- Dexterous Endoscopes — Experience variable stiffness endoscopes that adapt to your needs, delivering precision, control, and better outcomes for every patient.
Serpentine Ventures (SERV) is the investment arm of the Swiss startup group. Serpentine refers to the meandering roads found across the Swiss Mountains. Unreachable mountain peaks become accessible by following the serpentine path.
Show more...Investment focus
- Industry: Software, Information Technology, Automotive
- Stage:Seed, Pre-Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 88
- Round size: Seed $1.1M–$6.3M; Pre-Seed $110k–$1.5M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Evulpo — Evulpo is a free learning website that provides an instructional videos, summaries, and practice units for curriculum-related topics. Evulpo provides assistance with all relevant curriculum in the primary, secondary, high school, and BMS levels.
- Correntics — Our vision is to make global supply chains future-proof. With our data-driven approach, a deep understanding of risks, we help our clients to reduce risks in their value chains. Through our expertise, we support our clients to improve their operations and their financial resilience in the face of climate change and emerging risks while ensuring thesustainability of their business activities.
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
We invest in purpose driven founders with strong scientific background and the ambition to drive meaningful change and leave a world-positive footprint.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland, Belgium, Germany
Investor stats
- Total investments: 9
- Round size: Seed $1.2M–$7.7M; Pre-Seed $111k–$943k
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- ORamaVR — ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality.
- Anodyne Nanotech — Preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs.
- Eos Space Technology — Eos Space Technology develops electric propulsion systems for small satellites that fits within practical spacecraft size.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sparks Street Capital
Show more...Investment focus
- Industry: Wearables, Health Care, Medical Device
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 2
- Round size: Seed $4.1M–$6.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
Höhle der Löwen Schweiz
Show more...Investment focus
- Industry: E-Commerce, Retail, Farming
- Stage:Seed, Angel
- Geography: Switzerland
Investor stats
- Total investments: 16
- Round size: Seed $100k–$1.3M
- Lead/follow: 81% lead, 19% follow
Portfolio highlights
- Mtchbx — Mtchbx is engaged in the field of HR technology. It is revolutionizing the application process for applicants and companies. It is developing an intelligent and innovative service for recruitment. Also they offers AI match-making services for employers and job seekers eliminating extensive searching requirements.
- macu4 — We make innovative trendy orthopedic solutions by providing easy, fast, and gentle access to lightweight & breathable 3D printed devices.
- Splint Invest — Splint Invest is a B2B2C platform, where customers can buy tokens of alternative investments. Combining smart contracts, DLT and AI, we tokenize real-world assets effortless and fully automated.
Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team
Show more...Investment focus
- Industry: Health Care, Software, Wearables
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland, Italy, France
Investor stats
- Total investments: 24
- Round size: Seed $1M–$5.9M; Pre-Seed $667k–$1.6M; Series A $4.1M–$7M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $21M in 2022
Portfolio highlights
- Xsensio — Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
- ENANTIOS — ENANTIOS specializes in creating benchtop analytical instruments that provide industries, research institutions, and academic facilities.
- Develop Players — Supporto clinico per ADHD e DSA online. Aiutiamo adulti, bambini e ragazzi con screening, potenziamento e percorsi psicologici personalizzati.
Right People. Right Investments. Investing in European Seed DeepTech our portfolio latest insights Right People. Right Investments. Investing in European Seed DeepTech our portfolio latest insights About us EuroUS Ventures invests in companies which have passed the significant early stage hurdles of
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Switzerland, Israel, Austria
Investor stats
- Total investments: 14
- Round size: Seed $500k–$14M; Series A $650k–$9.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mictic — Mictic AG is a fast-growing startup dedicated to developing innovative user experience in Audio Augmented Reality. The Zurich-based company applies unique technology to profoundly change the way people interact with music and their own movements. Its mission is to make musical interaction more accessible to the masses. Never picked up an instrumentbefore? No problem. Already a Rock Star? We got you. Rock, Hip-Hop, EDM, Classical, Jazz: Get ready to make REAL music out of thin air!
- UNISERS — Developing solutions for Universal Contamination Analysis. Working with cutting edge technologies to revolutionize contamination control.
- Typewise — The best free smartphone keyboard app. Type faster with 4x fewer typos + 100% privacy. Next-gen hexagon keyboard, superior AI autocorrect & multi-language detection.
Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: Switzerland, United States, India
Investor stats
- Total investments: 36
- Round size: Series A $5M–$22M; Series B $11M–$73M; Series C $15M–$100M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — raised $113M in 2020
Portfolio highlights
- Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
- Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able to do in India yet. The website has over 500 designs of eye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery. Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision to name a few) and be it disposable, toric, colored, or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
- Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Long-term brain monitoring and therapeutics for personalized management of neuro-disorders
Show more...Investment focus
- Industry: Medical, Manufacturing, Medical Device
- Stage:Seed, Grant, Series A
- Geography: Switzerland
Investor stats
- Total investments: 5
- Round size: Grant $109k–$109k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Deegtal — dEEGtal’s use of AI to expedite epilepsy diagnosis could make a significant difference in patient care, by analyzing EEG data quickly, it might help identify patterns or anomalies that could be missed by human reviewers alone.
- Clee Medical — Clee Medical believes the rapid growth of neurotech is constrained by inefficiencies in surgical tools and techniques.
- ARTIRIA Medical — Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
Boosting health pioneers. We invest in early stage start-ups in different sectors: medtech, life science, biotech, mental health, public health, well-being.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 11
- Round size: Seed $1.6M–$6.8M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Hemostod — Developing universal platelets and next-generation diagnostics
- DigeHealth — DigeHealth is a Swiss company building a wearable that continuously listens to your gut, turning bowel sounds and body signals into a daily picture of your gut health.
- Allegria Therapeutics — Allegria Therapeutics is a Swiss biotech company targeting mast cells to redefine the treatment of allergic and inflammatory diseases.
Astanor Ventures is a venture capital firm focusing on entrepreneurs regenerating the food, blue ocean economy, and agriculture sector. The firm targeting technology-enabled companies across the agri-food value chain, leveraging disruptive technologies to bring about a future of food that is nourishing, regenerative, trusted, and ultra-fresh. It rings together capital, deep sector knowledge, and a strong network of entrepreneurs, impact investors, technologists, scientists, farmers, chefs, policymakers, and food lovers to give rise to a future of food that is nourishing, regenerative, scalable, trusted, and delicious.
Show more...Investment focus
- Industry: Agriculture, Biotechnology, AgTech
- Stage:Series A, Seed, Series B
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $442k–$17M; Series A $8M–$34M; Series B $18M–$61M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $384M in 2023
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- ProducePay — Founded by Pablo Borquez Schwarzbeck, a fourth-generation farmer, ProducePay is eliminating the economic and food waste caused by the volatile, opaque, and fragmented nature of today’s global fresh produce supply chain. The AgTech company’s Predictable Commerce Platform is giving growers and buyers greater control of their business by providingunprecedented access to each other, capital, trading, insights and greater supply chain visibility. Consumers receive fresher produce more efficiently, knowing it is grown and delivered in responsible ways. This transformational approach is unlocking economic value, and creating a more sustainable global fresh produce industry.
- Metabolize — Metabolize provdies wellness and fitness services that helps with global metabolic health and obesity epidemic
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 360
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- IMIO — Improve efficiency across the crop nutrient cycle. IMIO natural microbial products reliably increase nutrient availability and reduce tillage.
- DMC Biotechnologies — Transforming How the World Makes Chemicals
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 851
- Round size: Seed $680k–$6.5M; Series A $3M–$31M; Venture - Series Unknown $911k–$12M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Extoll — EXTOLL, a leader in high-speed, ultra-low power SerDes and Chiplet connectivity, offers semiconductor IP with the smallest footprints and highest PPA. Serving global ASIC, SoC, and Chiplet markets, our portfolio includes tailored NoC (Network-on-Chip) and Die-to-Die solutions. EXTOLL drives innovation, enabling successful migration into the Chiplet Age.
- Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: The Netherlands, United States, Germany
Investor stats
- Total investments: 93
- Round size: Seed $3.1M–$24M; Series A $3.4M–$42M; Series B $9M–$86M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $562M in 2016
Portfolio highlights
- Silverflow — Silverflow offers global payment technology to power financial institutions.
- Provable Markets — A comprehensive suite of trading & trade management solutions for the front, middle, and back office
- Quantum Motion — Quantum Motion Technologies is building a universal quantum computer in Silicon, using CMOS compatible processes.
TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the global market. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.
Show more...Investment focus
- Industry: Software, SaaS, Energy
- Stage:Seed, Series A, Pre-Seed
- Geography: Switzerland, Italy, United States
Investor stats
- Total investments: 23
- Round size: Seed $497k–$2M; Pre-Seed $800k–$1.4M; Series A $1.9M–$3.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- InkVivo — InkVivo provides clinicians and healthcare providers with a product delivery system that optimizes treatments. Their manufacturing approach allows users to design implantable patches, tablets, and injectable biomaterials.
- BigOmics — Get robust and reproducible results in a few clicks with Omics Playground: your user-friendly Omics Data Analysis Software.
- Jaipur Robotics — The leading computer vision and AI solutions for WtE and industrial plants. Boosting safety, efficiency, profitability and cutting emissions.
Molten Ventures is a leading British venture capital firm backing Europe’s highest-growth private technology companies. Our expert investment team stay ahead of the curve, identifying transformative trends and next-generation companies before they break through. We combine multiple pools of capital to invest at all stages of the business lifecycle—from seed and early stage to growth and late stage—focusing on disruptive sectors like Spacetech, Fintech, and AI. Our strategy is simple: back bold ideas, scale them with capital and expertise, and unlock high-value exits—whether through strategic acquisitions, trade buy-outs, or IPOs. Since our 2016 IPO, we’ve delivered strong realised returns, reinvesting into the next wave of innovation—creating a virtuous cycle of growth and value.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 235
- Round size: Series A $3.2M–$31M; Series B $8.3M–$60M; Series C $11M–$200M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $7M in 2011
Portfolio highlights
- StrikeAd — StrikeAd Fusion, a proprietary technology platform for agencies and advertisers to plan, execute, and evaluate their mobile advertisements. It is created to answer the ever growing need of media planning and buying agencies to manage their mobile campaigns effectively through a single platform. The company's platform is not a bolt on to anexisting DSP but a mobile-specific platform in its own right, a single console through which agencies can plan, execute and evaluate hundreds of mobile campaigns, minute-by-minute, on a global basis.
- MAIA Technology — MAIA is a cloud native, API-first platform that unifies mission-critical data, Portfolio Management, Trading & Compliance, Risk & Performance, IBOR and Middle Office workflows into one architecture.
- Mobile Travel Technologies — Mobile Travel Technologies (MTT) is the leading mobile travel technology specialist for airlines, hotels and travel intermediaries with an extensive customer base across the global travel industry.MTT’s advanced mobile travel platform powers some of the most successful and highest revenue generating mobile channels in the travel industry. As apioneer in this space having first launched mobile bookings for airlines in 2006, MTT has remained a first mover in mobile travel and has picked up many awards along the way for its successful, customer focused travel apps & mobile sites. MTT offers its clients unrivalled travel industry expertise, world-class mobile development, creative design, mobile usability expertise and a sophisticated mobile travel platform. MTT clients include Saudi Arabian Airlines (Saudia), the flag carrier for Kingdom of Saudi Arabia, LAN Airlines in Chile and TAM Airlines in Brazil (the LATAM Airlines Group), easyJet, transavia.com of the Air France KLM Group, Flybe, Jumeirah Group and Atlantis The Palm, Dubai.
Ecosystem Ventures is a venture capital investment and strategic consulting firm that offers related consultation services to seed stage companies. It is dedicated to building sustainable companies around significant technologies and innovative business ideas. The firm invests in companies during the seed round and works with entrepreneurs to grow their businesses until the first large institutional investment (Series A). It offers its business consulting support and services in the American, Indian, and European markets. Founded in 2005, Ecosystem Ventures is based in San Francisco, California.
Show more...Investment focus
- Industry: Mobile Apps, Mobile, Finance
- Stage:Seed, Series A, Angel
- Geography: United States, India, Switzerland
Investor stats
- Total investments: 28
- Round size: Seed $203k–$2M; Angel $500k–$1M; Series A $700k–$15M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- GeoIQ.io — GeoIQ helps India's leading brands make smarter location decisions with AI-powered site selection, territory planning, and consumer profiling.
- SpeEdLabs — SpeEdLabs is to provide a top-notch, technology-based Learning and Practice platform to students at an affordable price, thus empowering every student to grow into their full potential.
- Mindler — Discover your perfect career, stream, college & course with India's leading career counsellors. Career counselling & guidance programs for school, college students & graduates.
Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007. Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technical expertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services. Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series B, Series A, Series C
- Geography: Switzerland, United States, United Kingdom
Investor stats
- Total investments: 159
- Round size: Series A $2M–$22M; Series B $2M–$60M; Series C $8.6M–$80M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- Apono — Apono makes permission management to applications, infrastructure, and data repositories simple, secure and compliant.
- CDDS — The CDDS interceptor is an autonomous, kinetic counter drone designed to neutralize Group 1 and Group 2 Unmanned Aerial System (UAS) threats with speed and precision.
- Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey—based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES has a dedicated team of investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series C, Series A, Series B
- Geography: United States, Switzerland, Italy
Investor stats
- Total investments: 38
- Round size: Series A $1.4M–$24M; Series B $9M–$132M; Series C $11M–$66M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — raised $96M in 2009
Portfolio highlights
- Arvinas — Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
- Molecular Templates — Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
- Rivus Pharmaceuticals — Rivus Pharmaceuticals, a leader in mitochondrial biology, is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity.
Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Switzerland, United States, Spain
Investor stats
- Total investments: 53
- Round size: Seed $500k–$3.5M; Series A $2.1M–$10M; Venture - Series Unknown $1.3M–$5.4M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
- Hemostod — Developing universal platelets and next-generation diagnostics
- Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Founded in 1996 and after 27 years of competing in the investment banking sector, Boltendahl is characterized by its international focus, privy approach and strategic vision. Boltendahl’s agile and flexible structure enables to operate in several markets. We identify ourselves with our client's success to whom we dedicate a team of dealmakers who offer their maximum energy and creativeness.
Show more...Investment focus
- Industry: Mobile, Sensor, Medical
- Stage:Series A, Angel, Series B
- Geography: United States, Israel, Switzerland
Investor stats
- Total investments: 9
- Round size: Series A $9.7M–$10M; Series B $18M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ava — Ava is a patented multi-sensor bracelet, which allows women to precisely and conveniently predict fertile days.
- Corephotonics — Corephotonics is the pioneer and worldwide market leader of dual camera technologies for smartphones and mobile devices, providing a perfect mobile camera photography experience, novel photography features and superior image quality
- Clover Food Lab — Clover Food Lab is a fast food chain that operates through food trucks and restaurants. The company serves a food menu that changes day to day and with the seasons based on what is available from local farmers and includes a large mix of organic ingredients.Clover Food Lab was founded in 2008 by Massachusetts.
Initiative Capital Romandie is a private equity fund that focuses on technology companies based in Western Switzerland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series C, Series B
- Geography: Switzerland
Investor stats
- Total investments: 8
- Round size: Series A $6.8M–$10M; Series C $18M–$41M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Endosense — Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense's TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact forceduring the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.
- PicoDRILL — PicoDRILL generates technology leadership for its partner/customers through cutting-edge technology for drilling needs in the nanotechnology field. picoDrill is a private company located in Lausanne, Switzerland.
- Aleva Neurotherapeutics — Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage.Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use.Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 2171
- Round size: Series A $5.7M–$53M; Series B $10M–$85M; Series C $15M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $468M in 2024
Portfolio highlights
- Uhana — Modernize your RAN to be open and programmable, built with a rich ecosystem of partners. Learn about VMware RAN Intelligent Controller (RIC).
- erytech — ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.
- Sportsrocket — Sportsrocket is a New York-based company working to give sports fans access to live games and events, highlights, and shows. The company works with leading leagues, publishers, and rights-holders, including Major League Soccer, the PGA Tour, Scout Media, and AS Roma, to create and power customized OTT platforms. Incubated by Bedrocket Media Ventures, Sportsrocket's innovative approach is based on a proprietary sports media operating system, that offers an integrated solution for the production, distribution, management, and monetization of sports media across all platforms.
Medical Device VC funding in Switzerland at a glance
Stats across 673 deals from 394 investors.
Access all 394 VC funds in Switzerland Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 394 VC funds investing in Switzerland Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!